The aim of this document is to reinforce the need for urgent leadership from the Department of Health, PHE and NHS England and concerted action from Local Authorities, Health and Wellbeing Boards, Clinical Commissioning Groups (CCGs) and service providers to improve hepatitis C testing and treatment services in London for people with a history of using drugs – the group most affected by chronic hepatitis C – in order to find and treat significantly more people affected by the disease.
17 November 2014 | London Joint Working Group on Substance Use and Hepatitis C
Dr Vivian Hope of Public Health England said: "With around half of those people living with hepatitis C still unaware of their infection, we need to do more to increase diagnosis rates. Ultimately, this will help reduce the current high level of infection we’re still seeing among people who inject drugs."
05 November 2014 | Public Health England press release
While screening the blood samples of patients for HCV antibodies can be useful, a new study suggests that in some cases such antibodies may not appear for several months after HCV infection has occurred. In such cases, acute HCV infection might be missed if antibody tests alone are used for screening - RNA testing should be used to screen HCV infection.
17 September 2014 | CATIE
New figures from PHE reveal hospital admissions, liver transplants and deaths from hepatitis C (HCV) have all risen in the UK.
28 July 2014 | Public Health England
During this current legislative season, Project Inform sponsored California Senate Bill (SB) 1303, authored by Senator Norma Torres — a bill that would require healthcare practitioners in all primary care settings, except hospitals and emergency rooms, to make a one-time offer of a hepatitis C test to patients born between 1945 through 1965 (“Baby Boomers”) and other patients with identified risk factors for hepatitis C. The bill was modeled after legislation passed in New York State, based on hepatitis C testing recommendations by the Centers for Disease Control & Prevention (CDC) and the United States Preventive Services Task Force.
10 June 2014 | Project Inform
Medicare will cover HCV screening for all adults at high risk and one-time screening for all adults born between 1945 and 1965.
09 June 2014 | aids.gov
Developing simpler, quicker and more affordable viral load technologies is the key to vastly improved management of the hepatitis C virus.
09 April 2014 | UNITAID
The number of Americans who are infected with hepatitis C is falling, but that’s probably because more people who have been sickened by the virus are dying as a result, government researchers reported Monday.
04 March 2014 | Los Angeles Times
HIV positive people with hepatitis C coinfection who start combination antiretroviral therapy (ART) are less likely to develop decompensated liver disease, or liver failure, according to a study published in the March 1, 2014, edition of Clinical Infectious Diseases.
21 February 2014 | HIVandHepatitis.com
Hepatitis C patients who took low-dose aspirin after liver transplantation experienced slower fibrosis progression, researchers reported at the AASLD Liver Meeting this month in Washington, DC. Two other studies showed that cenicriviroc -- a drug being developed for HIV treatment that blocks both CCR5 and CCR2 cell surface receptors -- had anti-inflammatory and anti-fibrotic activity in mice and rats.
28 November 2013 | HIVandhepatitis.com